Amgen AMGN
NASDAQ AMGN
$439.33 +8.12 (+1.88%)
At close: Aug 21, 2026 · 4:00 PM EDT

Amgen (AMGN) Long-Term Investments (2013 - 2014)

Amgen (AMGN) posted quarterly Long-Term Investments of $3.4 billion for Q1 2014, little changed quarter-over-quarter from $3.4 billion in Q4 2013.

Amgen (AMGN) Long-Term Investments (2013 - 2014) Analysis & Trends

Amgen's Long-Term Investments history runs 2 years deep, the most recent figure standing at $3.4 billion for Q1 2014.

  • In Q1 2014, Long-Term Investments changed N/A year-over-year to $3.4 billion; the TTM figure through Mar 2014 stood at $3.4 billion (changed N/A YoY), while the FY2013 annual figure was $3.4 billion, changed N/A from the prior year.
  • Long-Term Investments for Q1 2014 stood at $3.4 billion, roughly flat from $3.4 billion in the prior quarter.
  • The five-year high for Long-Term Investments was $3.4 billion in Q1 2014, with the low at $3.4 billion in Q3 2013.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Long-Term Investments (Qtr)
1 Johnson & Johnson 652.20 Bn 631.44 Bn 17.26 Bn -
2 AbbVie 469.51 Bn 462.94 Bn 12.70 Bn 266.00 Mn
3 Merck 376.81 Bn 369.67 Bn 12.21 Bn 1.22 Bn
4 Novartis Ag 303.04 Bn 295.35 Bn 11.24 Bn 69.00 Mn
5 Astrazeneca 257.61 Bn 252.71 Bn 12.86 Bn 297.00 Mn
6 Amgen 237.37 Bn 223.38 Bn 7.24 Bn -
7 Gilead Sciences 181.73 Bn 178.55 Bn 6.22 Bn -
8 Pfizer 159.66 Bn 147.96 Bn 10.94 Bn 1.56 Bn
9 Gsk 106.24 Bn 102.07 Bn 8.24 Bn 135.51 Mn
10 Sanofi 55.07 Bn 47.69 Bn 10.79 Bn 3.73 Bn

Historic Data

Download Data
DateValue
Mar 31, 2014 3.41 Bn
Dec 31, 2013 3.41 Bn
Sep 30, 2013 3.41 Bn